유동성 젤라틴 지혈재 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)

The future of the global flowable gelatin haemostatic matrix market looks promising with opportunities in the neurosurgery, obstetrics & gynecology, orthopedic, general surgery, and otolaryngology markets. The global flowable gelatin haemostatic matrix market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive surgeries, the growing need for effective hemostatic agents in trauma care, and the increasing preference for biologically-derived materials in medical applications.

• Lucintel forecasts that, within the type category, porcine gelatin is expected to witness higher growth over the forecast period.
• Within the application category, general surgery is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market is influenced by various emerging trends that are aimed at maximizing their haemostatic effectiveness, optimizing their handling characteristics, and extending their clinical applications.

• Combination with Active Hemostatic Agents to Improve Efficacy: Another important trend involves the combination of flowable gelatin matrices with active haemostatic agents including thrombin, fibrinogen, or oxidized cellulose. These are designed to impart synergistic action, resulting in more rapid and effective hemostasis, especially in difficult bleeding situations.
• Design of Ready-to-Use Products for Easy Application: An increased emphasis exists on designing ready-to-use flowable gelatin haemostatic matrices that make reconstitution or preparation unnecessary. Such formulations enhance convenience, shorten operating room time, and lower the potential for preparation mistakes.
• Combination with Antimicrobial Agents to Minimize Infection Risk: A new trend is the combination of antimicrobial agents with flowable gelatin haemostatic matrices. This is intended to offer hemostasis while also minimizing the risk of surgical site infection, an important issue in postoperative management.
• Biodegradability and Tissue Integration Improvements: Research is aimed at maximizing the biodegradability of flowable gelatin matrices to allow full absorption without residual material that might hinder healing or induce adverse reactions. Enhanced tissue integration is also a primary target.
• Injectable and Targeted Delivery System Development: Development of injectable and targeted delivery systems is a growing trend towards creating flowable gelatin haemostatic matrices that are deliverable by minimally invasive methods or targeted to the specific sites of bleeding using special applicators or catheters, further increasing their use in laparoscopic and endoscopic surgery.

These trends are transforming the flowable gelatin haemostatic matrix market by propelling innovation towards products with greater haemostatic performance, better convenience, lower risk of infection, and broader applicability to multiple surgical specialties. The emphasis on combination therapy, ready-to-use presentation, antimicrobial activity, biodegradability optimization, and sophisticated delivery systems is directed at enhancing surgical results and patient protection.

Recent Developments in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix industry is marked by continuous research aimed at maximizing the material properties and usage in operating rooms.

• Advanced Gelatin Processing Methods: One of the important advancements is improvements in the processing of gelatin to produce matrices with maximum particle size, porosity, and swelling capacity. Such refinement results in increased surface area for platelet adhesion and aggregation, thus providing more efficient hemostasis.
• Cross-Linked Gelatin Matrix Development: Cross-linking of gelatin molecules is also being investigated to improve the mechanical strength and resistance to degradation of flowable haemostatic matrices. This has the potential to deliver more sustained hemostasis, especially in high-flow bleeding.
• Imaging Agent Integration for Intraoperative Visualization: Certain companies are exploring the integration of imaging agents into flowable gelatin haemostatic matrices to enable improved intraoperative visualization of the material applied using methods such as fluorescence imaging.
• Production of Matrices with Regulated Swelling Character: The ability of flowable gelatin haemostatic matrices to swell to a maximum requires regulation so as not to build up too much pressure on contiguous tissues while facilitating sealing of wounds. Advances address controlled and pre-programmed swelling.
• Introduction of Ergonomic and Accurate Delivery Systems: Companies are working towards the development of easy-to-use delivery systems, including pre-filled applicators with fine tips, enabling accurate and controlled application of the flowable gelatin matrix at the site of bleeding, even in hard-to-reach locations.

These advancements are profoundly affecting the flowable gelatin haemostatic matrix market by offering surgeons more efficient, versatile, and convenient instruments for rapid and consistent hemostasis. The emphasis on optimized gelatin characteristics, cross-linking, intraoperative visualization, controlled swelling, and targeted delivery leads to enhanced surgical outcomes and patient safety.

Strategic Growth Opportunities in the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market provides some strategic growth opportunities through many of the major surgical applications.

• Cardiovascular Surgery: The requirement for efficient and biocompatible haemostatic agents in complicated cardiovascular procedures, such as cardiac and vascular surgeries, is a strong growth opportunity for flowable gelatin haemostatic matrices, especially those with active agents.
• Orthopedic Surgery: Maintenance of hemostasis in orthopedic operations, particularly during large joint arthroplasties and spine surgery, is important. The flowable gelatin matrices have a useful place in controlling oozing hemorrhage in such situations and pose a large growing opportunity.
• Neurosurgery: Hemostasis in refined neurosurgical interventions demands highly biocompatible materials with favorable application ease. Flowable gelatin matrices pose an effective, safe solution to haemostatic bleeding control within the central nervous system, identifying a major opportunity for growth.
• General Surgery and Trauma: The wide variety of general surgical procedures and trauma cases commonly present with major bleeding. Flowable gelatin haemostatic matrices offer a general-purpose solution to achieve hemostasis quickly in these varied situations, offering a huge growth opportunity.
• Minimally Invasive Surgery (MIS): Growing use of MIS technologies, including laparoscopy and endoscopy, generates a need for haemostatic products that will be easily delivered via small incisions or endoluminal lumen. Flowable gelatin matrices with sophisticated delivery systems are particularly suited for these uses, providing a major opportunity for growth.

Seizing these strategic growth opportunities necessitates that manufacturers create flowable gelatin haemostatic matrices that are customized to meet the unique demands of each surgical specialty. This involves optimizing the formulation, delivery system, and performance characteristics to meet the distinct challenges and needs of cardiovascular, orthopedic, neurosurgical, general, trauma, and minimally invasive surgeries.

Flowable Gelatin Haemostatic Matrix Market Driver and Challenges

The market for flowable gelatin haemostatic matrices is driven by a mix of factors that promote its use and pose some challenges to its growth and development.

The factors responsible for driving the flowable gelatin haemostatic matrix market include:

1. Growing Number of Surgical Procedures: The growing number of surgical procedures being conducted worldwide, fueled by an aging population and improved surgical techniques, directly boosts the demand for effective haemostatic agents such as flowable gelatin matrices.

2. Increasing Demand for Advanced Hemostatic Products: Surgeons are increasingly demanding advanced haemostatic products that provide quick, consistent, and biocompatible bleeding control over conventional techniques, fueling the use of flowable gelatin matrices.

3. Multifaceted Use Across Different Surgical Specialties: The versatility of flowable gelatin haemostatic matrices in being used across a wide variety of surgical specialties such as cardiovascular, orthopedic, neurosurgery, and general surgery supports their high market demand.

4. Friendly Biocompatibility and Safety Profile: Gelatin is a biocompatible and natural material with an established safety profile, and flowable gelatin matrices are hence a popular choice among surgeons worried about tissue reaction and long-term consequences.

5. Sustained Product Development and Innovation: Active development and research activities aimed at improving the efficacy, workability, and use of flowable gelatin matrices are resulting in better products and increasing their clinical applications.

Challenges in the flowable gelatin haemostatic matrix market are:

1. Competition from Other Advanced Hemostatic Agents: The market for flowable gelatin haemostatic matrices is competitively challenged by other advanced haemostatic products, including oxidized regenerated cellulose, collagen hemostats, and synthetic sealants, which can provide various benefits in certain surgical contexts.

2. Cost Considerations in Healthcare Systems: The price of advanced haemostatic agents, such as flowable gelatin matrices, can be a major determinant, especially in cost-sensitive markets or in those healthcare systems with limited budgets.

3. Proper Training and Usage Protocols: Proper training of surgical personnel on preparation and application methods is crucial for the successful application of flowable gelatin haemostatic matrices to achieve optimal hemostasis with minimal complications.

The rising number of surgical procedures, the increased demand for sophisticated haemostatic products, and the versatility and beneficial biocompatibility of flowable gelatin matrices are prime drivers behind the expansion of this market. Continuous product development further adds to their attractiveness. Nevertheless, competition from other haemostatic agents, economic factors, and the requirement for adequate training create challenges that need to be met by manufacturers and healthcare professionals in order to provide continued and universal acceptance of flowable gelatin haemostatic matrices in surgery.

List of Flowable Gelatin Haemostatic Matrix Companies

• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, flowable gelatin haemostatic matrix companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the flowable gelatin haemostatic matrix companies profiled in this report include:
• Ferrosan Medical Devices
• Baxter
• Aegis Lifesciences
• Pfizer
• Jiangxi Boenrui
• Beijing Nashi Biosurgery
• Shenzhen HUANOVA

Flowable Gelatin Haemostatic Matrix Market by Segment

The study includes a forecast for the global flowable gelatin haemostatic matrix market by type, application, and region.

Flowable Gelatin Haemostatic Matrix Market by Type [Value from 2019 to 2031]:

• Porcine Gelatin
• Bovine Gelatin

Flowable Gelatin Haemostatic Matrix Market by Application [Value from 2019 to 2031]:

• Neurosurgery
• Obstetrics & Gynecology
• Orthopedics
• General Surgery
• Otolaryngology
• Others

Flowable Gelatin Haemostatic Matrix Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Flowable Gelatin Haemostatic Matrix Market

The flowable gelatin haemostatic matrix market industry is a major area of surgical hemostasis, providing a biocompatible and efficient option for the management of bleeding in a variety of surgical applications. Recent trends throughout the United States, China, Germany, India, and Japan represent a worldwide tendency towards increased efficacy, greater ease of handling, and increased usage. Gelatin processing innovations, the addition of adjunctive haemostatic agents, and developments in delivery systems are primary areas of interest. Market forces are also driven by the expanding number of surgical procedures and the growing need for advanced haemostatic products with fast and consistent bleeding control.

• United States: The American market is noted for having a high rate of adoption of state-of-the-art haemostatic technologies and strong product innovation. Some of the recent advances have been the launch of flowable gelatin matrices with improved swelling ability for greater wound sealing and the addition of thrombin or other clotting factors to speed up hemostasis. An emphasis has also been placed on creating products that are simple to prepare and use in a wide range of surgery.
• China: The Chinese market is seeing tremendous growth in the medical device market, including haemostatic devices. Recent news includes the expanding domestic production of flowable gelatin matrices, frequently at lower prices. In addition, there is a focus on enhancing the quality and effectiveness of these locally produced products to address the needs of a fast-growing healthcare system.
• Germany: Highly technologically advanced in medicine, Germany has a trend in advanced flowable gelatin haemostatic matrices with defined performance attributes and biocompatibility. Some of the recent advancements include gelatin particle size and distribution optimization for increased surface area and clotting rate. User-friendly packaging and delivery forms as well as exact application are also emphasized.
• India: The Indian market is experiencing growing acceptance of newer surgical techniques and rising demand for efficient haemostatic agents. Recent trends have been the increasing availability of flowable gelatin matrices from both domestic and foreign suppliers. Increasing emphasis is also being placed on cost-effective products that offer consistent hemostasis in a variety of surgical specialties.
• Japan: Japan's market is focusing on high-quality and safety considerations in medical devices. Some new developments include introducing flowable gelatin haemostatic matrices that have improved biodegradability and low tissue reaction. Also emphasized are products that provide immediate and sustained hemostasis to lead to enhanced surgical outcomes as well as minimized postoperative complications.

Features of the Global Flowable Gelatin Haemostatic Matrix Market

• Market Size Estimates: Flowable gelatin haemostatic matrix market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Flowable gelatin haemostatic matrix market size by type, application, and region in terms of value ($B).
• Regional Analysis: Flowable gelatin haemostatic matrix market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the flowable gelatin haemostatic matrix market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the flowable gelatin haemostatic matrix market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the flowable gelatin haemostatic matrix market by type (porcine gelatin and bovine gelatin), application (neurosurgery, obstetrics & gynecology, orthopedics, general surgery, otolaryngology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Flowable Gelatin Haemostatic Matrix Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Porcine Gelatin: Trends and Forecast (2019-2031)
• 4.4 Bovine Gelatin: Trends and Forecast (2019-2031)

5. Global Flowable Gelatin Haemostatic Matrix Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Neurosurgery: Trends and Forecast (2019-2031)
• 5.4 Obstetrics & Gynecology: Trends and Forecast (2019-2031)
• 5.5 Orthopedics: Trends and Forecast (2019-2031)
• 5.6 General Surgery: Trends and Forecast (2019-2031)
• 5.7 Otolaryngology: Trends and Forecast (2019-2031)
• 5.8 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Flowable Gelatin Haemostatic Matrix Market by Region

7. North American Flowable Gelatin Haemostatic Matrix Market

• 7.1 Overview
• 7.2 North American Flowable Gelatin Haemostatic Matrix Market by Type
• 7.3 North American Flowable Gelatin Haemostatic Matrix Market by Application
• 7.4 United States Flowable Gelatin Haemostatic Matrix Market
• 7.5 Mexican Flowable Gelatin Haemostatic Matrix Market
• 7.6 Canadian Flowable Gelatin Haemostatic Matrix Market

8. European Flowable Gelatin Haemostatic Matrix Market

• 8.1 Overview
• 8.2 European Flowable Gelatin Haemostatic Matrix Market by Type
• 8.3 European Flowable Gelatin Haemostatic Matrix Market by Application
• 8.4 German Flowable Gelatin Haemostatic Matrix Market
• 8.5 French Flowable Gelatin Haemostatic Matrix Market
• 8.6 Spanish Flowable Gelatin Haemostatic Matrix Market
• 8.7 Italian Flowable Gelatin Haemostatic Matrix Market
• 8.8 United Kingdom Flowable Gelatin Haemostatic Matrix Market

9. APAC Flowable Gelatin Haemostatic Matrix Market

• 9.1 Overview
• 9.2 APAC Flowable Gelatin Haemostatic Matrix Market by Type
• 9.3 APAC Flowable Gelatin Haemostatic Matrix Market by Application
• 9.4 Japanese Flowable Gelatin Haemostatic Matrix Market
• 9.5 Indian Flowable Gelatin Haemostatic Matrix Market
• 9.6 Chinese Flowable Gelatin Haemostatic Matrix Market
• 9.7 South Korean Flowable Gelatin Haemostatic Matrix Market
• 9.8 Indonesian Flowable Gelatin Haemostatic Matrix Market

10. ROW Flowable Gelatin Haemostatic Matrix Market

• 10.1 Overview
• 10.2 ROW Flowable Gelatin Haemostatic Matrix Market by Type
• 10.3 ROW Flowable Gelatin Haemostatic Matrix Market by Application
• 10.4 Middle Eastern Flowable Gelatin Haemostatic Matrix Market
• 10.5 South American Flowable Gelatin Haemostatic Matrix Market
• 10.6 African Flowable Gelatin Haemostatic Matrix Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Flowable Gelatin Haemostatic Matrix Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Ferrosan Medical Devices
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Baxter
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Aegis Lifesciences
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Pfizer
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Jiangxi Boenrui
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Beijing Nashi Biosurgery
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Shenzhen HUANOVA
  • Company Overview
  • Flowable Gelatin Haemostatic Matrix Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us